Format

Send to

Choose Destination
Biochim Biophys Acta Mol Basis Dis. 2018 Nov 6. pii: S0925-4439(18)30435-6. doi: 10.1016/j.bbadis.2018.10.032. [Epub ahead of print]

Ferutinin directs dental pulp-derived stem cells towards the osteogenic lineage by epigenetically regulating canonical Wnt signaling.

Author information

1
Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USA.
2
Department of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, OH, USA.
3
Division of Periodontology, College of Dentistry, The Ohio State University, Columbus, OH, USA.
4
Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USA; Department of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, OH, USA. Electronic address: hiranmoy.das@ttuhsc.edu.

Abstract

Osteoporosis is a silent systemic disease that causes bone deterioration, and affects over 10 million people in the US alone. This study was undertaken to develop a potential stem cell therapy for osteoporosis. We have isolated and expanded human dental pulp-derived stem cells (DPSCs), characterized them, and confirmed their multipotential differentiation abilities. Stem cells often remain quiescent and require activation to differentiate and function. Herein, we show that ferutinin activates DPSCs by modulating the Wnt/β-catenin signaling pathway and key osteoblast-secreted proteins osteocalcin and collagen 1A1 both mRNA and protein levels. To confirm that ferutinin modulates the Wnt pathway, we inhibited glycogen synthase kinase 3 (GSK3) and found that protein expression patterns were similar to those found in ferutinin-treated DPSCs. To evaluate the role of ferutinin in epigenetic regulation of canonical Wnt signaling, the pathway molecules Wnt3a and Dvl3 were analyzed using chromatin immunoprecipitation (ChIP)-quantitative PCR approaches. We confirmed that active marks of both H3K9 acetylation and H3K4 trimethylation were significantly enhanced in the promoter sites of the WNT3A and DVL3 genes in DPSCs after addition of ferutinin. These data provide evidence that ferutinin activates and promotes osteogenic differentiation of DPSCs, and could be used as an inducer as a potentially effective stem cell therapy for osteoporosis.

KEYWORDS:

DPSC; Epigenetic regulation; Ferutinin; Osteogenic differentiation; Wnt/β-catenin

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center